AI-064

N/A

Report date: 2024/11/15 14:03:51

Base Information

Drug NameAI-064
Drug Alias NameAI-064
ClassificationBiologics
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsVascular endothelial growth factor inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Vascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAcroImmune Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcroImmune Group
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A